Asabys Partners is a Barcelona-based venture capital firm specialized in healthcare and life sciences innovation, including biopharma, medical devices, and digital health. Founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, the firm invests in companies developing novel solutions for unmet medical needs.
Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $64.5M (across 7 rounds with reported amounts).
Portfolio
17
Fund Size
$200M
Top Stage
Series C
Last 12 Mo
4
Team
Clara Campàs
Co-founder and managing partner
Josep Ll. Sanfeliu
Co-founder and managing partner
José María Fernández
Partner
Montse Vendrell
Partner
Sylvain Sachot
Partner
Isabel Jimenez
Principal
Maite Malet
Principal
Antonio Limatola
Senior Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| OOriva | Pre-Seed | — | Jan 2026 |
 Qida | Growth | — | Nov 2025 |
 Safeheal SAS | Series C | — | Sep 2025 |
| SSafeHeal | Series C | $10M | Sep 2025 |
 SpliceBio | Series B | $135M | Jun 2025 |
| SSplice Bio | Series B | $135M | Jun 2025 |
 DeePuLL | Series C | — | Apr 2025 |
| DDEEPULL DIAGNOSTICS, S.L. | Series C | — | Apr 2025 |
 Augustine Therapeutics | Series A | — | Mar 2025 |
 Orikine Bio | Seed | — | Jan 2023 |
| SpliceBio | Series A | — | Feb 2022 |
| DeePuLL | Series B | — | Jan 2022 |
| IINBRAIN NEUROELECTRONICS, S.L. | Series A | $16.8M | Jan 2021 |
 Medasense | Series C | $18M | Sep 2020 |
| IINBRAIN NEUROELECTRONICS, S.L. | Seed | — | Jan 2020 |
 Medlumics | Series E | — | — |
 Gradient Denervation Technologies | Series A | — | — |
 Nuage Therapeutics | Seed | — | — |
 Nuage | Seed | — | — |
| IINBRAIN NEUROELECTRONICS, S.L. | Series B | $50M | — |
 ONA | Series B | $86.6M | — |
Top Co-Investors
Last updated: 8 September 2026